Kathleen S. Wright Associates Inc. Pds Biotechnology Corp Transaction History
Kathleen S. Wright Associates Inc.
- $215 Million
- Q1 2024
A detailed history of Kathleen S. Wright Associates Inc. transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Kathleen S. Wright Associates Inc. holds 7,000 shares of PDSB stock, worth $20,650. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,000Holding current value
$20,650% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
76Shares Held
7.53MCall Options Held
140KPut Options Held
318K-
Black Rock Inc. New York, NY1.87MShares$5.51 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.59MShares$4.68 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA654KShares$1.93 Million0.0% of portfolio
-
State Street Corp Boston, MA557KShares$1.64 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC355KShares$1.05 Million0.23% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $84M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...